Haemonetics Corp. (HAE)

102.92 +0.07 (+0.07%) USD  |  NYSE  |  Sep 04, 16:00
102.89 -0.03 (-0.03%) Pre-Market: 20:00
More

Haemonetics SG&A Expense (TTM) : 451.54M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for HAE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 451.54M
March 31, 2026 443.32M
December 31, 2025 436.85M
September 30, 2025 434.15M
June 30, 2025 439.48M
March 31, 2025 437.01M
December 31, 2024 443.33M
September 30, 2024 448.59M
June 30, 2024 446.54M
March 31, 2024 431.78M
December 31, 2023 407.48M
September 30, 2023 390.42M
June 30, 2023 377.93M
March 31, 2023 376.68M
December 31, 2022 371.14M
September 30, 2022 357.20M
June 30, 2022 340.57M
March 31, 2022 339.56M
December 31, 2021 331.43M
September 30, 2021 324.15M
June 30, 2021 320.07M
March 31, 2021 298.39M
December 31, 2020 293.26M
September 30, 2020 298.08M
June 30, 2020 296.22M
Date Value
March 31, 2020 299.68M
December 31, 2019 299.71M
September 30, 2019 295.32M
June 30, 2019 302.73M
March 31, 2019 298.28M
December 31, 2018 298.69M
September 30, 2018 322.67M
June 30, 2018 318.21M
March 31, 2018 316.52M
December 31, 2017 310.59M
September 30, 2017 283.69M
June 30, 2017 282.02M
March 31, 2017 302.66M
December 31, 2016 312.60M
September 30, 2016 320.58M
June 30, 2016 324.03M
March 31, 2016 324.14M
December 31, 2015 320.72M
September 30, 2015 324.54M
June 30, 2015 334.74M
March 31, 2015 339.69M
December 31, 2014 347.34M
September 30, 2014 354.14M
June 30, 2014 350.88M
March 31, 2014 365.13M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 1.217B
Abbott Laboratories 13.94B
AngioDynamics, Inc. 157.09M
Alphatec Holdings, Inc. 524.06M
AtriCure, Inc. 323.68M